The prime focus of Insignia Strategies, LLC is to help companies obtain the greatest value for their pharmaceutical portfolios. Our seasoned team of industry experts can help maximize your products and pipeline. The team and individuals bring real life experience to the table and cover all aspects of product strategy, acquisition, development, regulatory approval, manufacturing, commercialization, including managed market contracting, medical education, and more. Our experts can also help evaluate product acquisitions and divestments. The experience spans most all therapeutic areas and includes oral solids, injectables, biologics, and devices, in both brand and generic markets. To accomplish these goals, we have assembled executive level experts with experience in commercial strategy, business development, and regulatory and legal strategies for both small and large pharmaceutical companies. Our team includes former Executive leadership (CEO, GM), as well as heads of Commercial Functions, Business Development, Regulatory, Legal, and Compliance. If you are seeking experienced advisers on your critical assets and decisions or are seeking to create growth or scale your business, we can help. Insignia Strategies, LLC TEAM: Larry Downey – (Former President and CEO, North America Brand Business) Michael McHugh – (Former SVP/GM North America Business Unit and VP Business Development) Mike Nicholas – (Former, SVP Global Life Cycle Management, Head of North America Regulatory Affairs) James Rodenberg – (Former VP Legal and General Counsel North America)